Annual Accounts Receivable
$6.34 M
+$1.94 M+44.11%
December 31, 2021
Summary
- As of February 10, 2025, CRXT annual accounts receivable is $6.34 million, with the most recent change of +$1.94 million (+44.11%) on December 31, 2021.
- During the last 3 years, CRXT annual accounts receivable has risen by +$1.94 million (+44.11%).
Performance
CRXT Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Accounts Receivable
$8.71 M
+$700.00 K+8.74%
June 30, 2022
Summary
- As of February 10, 2025, CRXT quarterly accounts receivable is $8.71 million, with the most recent change of +$700.00 thousand (+8.74%) on June 30, 2022.
Performance
CRXT Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
CRXT Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +44.1% | - |
| 3 y3 years | +44.1% | - |
| 5 y5 years | +44.1% | - |
CRXT Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | at high | -27.2% |
| 5 y | 5-year | at high | -30.6% | at high | -49.5% |
| alltime | all time | at high | -30.6% | at high | -49.5% |
Clarus Therapeutics Holdings Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $8.71 M(+8.7%) |
| Mar 2022 | - | $8.01 M(+26.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $6.34 M(+44.1%) | $6.34 M(-8.5%) |
| Sep 2021 | - | $6.93 M(+57.5%) |
| Dec 2020 | $4.40 M | $4.40 M |
FAQ
- What is Clarus Therapeutics Holdings annual accounts receivable?
- What is the all time high annual accounts receivable for Clarus Therapeutics Holdings?
- What is Clarus Therapeutics Holdings annual accounts receivable year-on-year change?
- What is Clarus Therapeutics Holdings quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Clarus Therapeutics Holdings?
What is Clarus Therapeutics Holdings annual accounts receivable?
The current annual accounts receivable of CRXT is $6.34 M
What is the all time high annual accounts receivable for Clarus Therapeutics Holdings?
Clarus Therapeutics Holdings all-time high annual accounts receivable is $6.34 M
What is Clarus Therapeutics Holdings annual accounts receivable year-on-year change?
Over the past year, CRXT annual accounts receivable has changed by +$1.94 M (+44.11%)
What is Clarus Therapeutics Holdings quarterly accounts receivable?
The current quarterly accounts receivable of CRXT is $8.71 M
What is the all time high quarterly accounts receivable for Clarus Therapeutics Holdings?
Clarus Therapeutics Holdings all-time high quarterly accounts receivable is $8.71 M